Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...
The Brighterside of News on MSN17h
Gene discovery revolutionizes the detection and treatment of prostate cancerProstate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...
Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...
Two abstracts on Clarity’s diagnostic COBRA and CLARIFY trials with 64Cu-SAR-bisPSMA have been accepted for presentation at the American Society of Clinical Oncology Genitourinary Cancers Symposium ...
Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...
A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has ...
I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level ...
The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...
The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback